Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II

1993 ◽  
Vol 157 (1) ◽  
pp. 178-183 ◽  
Author(s):  
Shoshana Merchav ◽  
Mats Lake ◽  
Anna Skottner
Endocrinology ◽  
1986 ◽  
Vol 118 (5) ◽  
pp. 2034-2038 ◽  
Author(s):  
PETRO E. PETRIDES ◽  
RAYMOND L. HINTZ ◽  
PETER BOHLEN ◽  
JOHN E. SHIVELY

1984 ◽  
Vol 18 (11) ◽  
pp. 1206-1206 ◽  
Author(s):  
M Jansen ◽  
H H M Van Tol ◽  
F M A Van Schaik ◽  
J L Van Den Brande ◽  
J S Sussenbach

1988 ◽  
Vol 8 (3) ◽  
pp. 293-297 ◽  
Author(s):  
M. Tally ◽  
K. Florell ◽  
G. Enberg

The separation of human insulin-like growth factors hIGF-1 and hIGF-2 was greatly improved by an additional purification step using the cation exchanger Mono-S (FPLC) compared to previous studies. Cross-reactions between hIFG-1 and hIGF-2 were strongly reduced. The more highly purified hIGF-1 had a cross-reaction of less than 1% in the RIA for hIGF-2, and was equivalent to recombinant hIGF-1. The pure hIGF-2 had a cross-reaction of less than 1% in the RIA for hIGF-1. In the human placental hIGF-2 radioreceptor assay, the hIGF-1 polypeptide competed less than 1% with hIGF-2 when the type 1 IGF receptor was blocked with insulin.


1984 ◽  
Vol 10 (2) ◽  
pp. 101-112 ◽  
Author(s):  
Richard A. Roth ◽  
Mary L. Mesirow ◽  
Koichi Yokono ◽  
Shigeaki Baba

Sign in / Sign up

Export Citation Format

Share Document